Latest Insider Transactions at Instil Bio, Inc. (TIL)
This section provides a real-time view of insider transactions for Instil Bio, Inc. (TIL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Instil Bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Instil Bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
R Kent Mc Gaughy Jr Director |
SELL
Other acquisition or disposition
|
Indirect |
260,323
-3.07%
|
-
|
|
Mar 23
2021
|
Bronson Crouch CEO and Chairman |
BUY
Open market or private purchase
|
Indirect |
450,000
+1.17%
|
$9,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
Bronson Crouch CEO and Chairman |
BUY
Conversion of derivative security
|
Indirect |
37,530,073
+22.71%
|
-
|
|
Mar 23
2021
|
R Kent Mc Gaughy Jr Director |
BUY
Open market or private purchase
|
Indirect |
450,000
+5.04%
|
$9,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
R Kent Mc Gaughy Jr Director |
BUY
Conversion of derivative security
|
Indirect |
8,028,790
+30.31%
|
-
|
|
Mar 23
2021
|
Jack Nielsen Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+2.35%
|
$6,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
Jack Nielsen Director |
BUY
Conversion of derivative security
|
Indirect |
12,186,787
+26.88%
|
-
|
|
Mar 23
2021
|
Nimish P Shah Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+24.0%
|
$6,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
Nimish P Shah Director |
BUY
Conversion of derivative security
|
Indirect |
6,565,076
+32.89%
|
-
|
|
Mar 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+2.35%
|
$6,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
12,186,787
+26.88%
|
-
|
|
Mar 23
2021
|
Curative Ventures V LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
450,000
+1.17%
|
$9,000,000
$20.0 P/Share
|
|
Mar 23
2021
|
Curative Ventures V LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
37,530,073
+22.71%
|
-
|